Published in PLoS One on August 01, 2014
Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science (1998) 5.05
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol (2004) 3.57
The papillomavirus life cycle. J Clin Virol (2005) 3.41
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol (2000) 2.55
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst (2006) 2.40
Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36
Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect (1998) 2.22
A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods (2001) 2.15
Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer (1999) 2.04
Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol (2006) 2.02
HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods (2002) 1.97
E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog (2011) 1.89
Cross-roads in the classification of papillomaviruses. Virology (2013) 1.87
The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42
Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol (2006) 1.39
The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol (2013) 1.36
The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol (2007) 1.27
Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol (2002) 1.23
Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol (2007) 1.21
Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol (2004) 1.20
Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ (2010) 1.18
The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol (2013) 1.18
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet (2012) 1.10
The emerging role of HLA-C in HIV-1 infection. Immunology (2011) 1.06
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology (2011) 1.05
High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol (2008) 1.02
Tea consumption and basal cell and squamous cell skin cancer: results of a case-control study. J Am Acad Dermatol (2007) 1.02
Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol (2013) 1.00
Pathogenesis of nonmelanoma skin cancers in organ transplant recipients. Arch Biochem Biophys (2011) 1.00
XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis (2006) 0.99
EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One (2012) 0.97
Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer (2008) 0.95
Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer (2013) 0.91
EVER2 deficiency is associated with mild T-cell abnormalities. J Clin Immunol (2012) 0.91
Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients. Skinmed (2007) 0.89
Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer (2013) 0.89
Taxonomy and phylogeny of papillomaviruses: an overview and recent developments. Infect Genet Evol (2013) 0.88
Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol (1990) 0.88
Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients. Mod Pathol (2014) 0.85
Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis. J Invest Dermatol (2011) 0.83
Genome-wide association study of HPV seropositivity. Hum Mol Genet (2011) 0.82
Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients. PLoS One (2012) 0.79
Role of Human Papillomavirus in Penile Carcinomas Worldwide. Eur Urol (2016) 1.07
Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev (2015) 0.89
Human polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer study. Cancer Med (2016) 0.75
Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers. Br J Cancer (2016) 0.75
HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. Papillomavirus Res (2016) 0.75
Pre-analytical stability of antibodies to pathogenic antigens. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Human papillomavirus and post-transplant cutaneous squamous-cell carcinoma: a multicenter, prospective cohort study. Am J Transplant (2017) 0.75
Assessment of the Combined Effect of Epstein-Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach. Front Immunol (2017) 0.75